Upsher-Smith Laboratories, LLC. (Upsher-Smith) today announced the launch of KLOR-CON® Powder (Potassium Chloride) for oral solution, 20 mEq. The Company received approval of an abbreviated new drug application (ANDA) from the U.S. Food and Drug Administration (FDA) for this product, which will be marketed and distributed by Upsher-Smith. Sandoz, Inc. will continue as the licensed marketer and distributor in the U.S. for the balance of the KLOR-CON® line of potassium products.
The potassium chloride powder market had U.S. sales of approximately $98 million for the 12 months ending September, 2017 according to IMS Health.
The NDC numbers for KLOR-CON® Powder (Potassium Chloride) for oral solution, 20 mEq are 0245-0360-30 for cartons of 30 packets and 0245-0360-01 for cartons of 100 packets. For questions about ordering, please call Upsher-Smith at 1-800-654-2299.
Please refer to the full Prescribing Information for KLOR-CON® Powder at https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=e61a4522-b91d-400a-952c-6f035e4610dd&type=display. You can also visit www.upsher-smith.com or call 1-888-650-3789.
You are encouraged to report suspected adverse reactions to Upsher-Smith Laboratories, LLC at 1-855-899-9180 or to the FDA by visiting http://www.fda.gov/medwatch.
KLOR-CON is a registered trademark of Upsher-Smith Laboratories, LLC.
Related Coverage
For more reporting on this topic, see our Prescription Drugs and Pharmacy news hub.